Pharmaceutical Commerce·· 2 小时前AI 评分22
Avantor 的 Mary Blenn 谈生物制药供应链本地化：从需求可见性到成本、一致性与冗余的五项考量
BioPharma Supply Chains of the Future: What to Know About Localization
AI 导读
Avantor 的 Mary Blenn 提出生物制药供应链本地化的五项考量，涵盖客户需求可见性、成本、一致性与冗余。她指出，各国销售与市场组织常向首席运营官、供应链负责人和生产负责人反映，若没有能快速适应当地需求的本地布局，就难以取得成功。
正文
News|Articles|October 16, 2026
Avantor’s Mary Blenn outlines five considerations for biopharma supply chain localization, from customer demand visibility to cost, consistency and redundancy.
It’s a common refrain heard by chief operating officers, supply chain leaders and manufacturing heads from country-level sales and marketing organizations — we can’t succeed without having a local footprint that can quickly adapt to demand on the ground.
Related to this article
来源：Pharmaceutical Commerce · pharmaceuticalcommerce.com